Richard Eglen, John Wang
Mike Biros, Heidi Bullock
- Cell Signaling Technology
- DiscoveRx
- MDS Sciex
- CyBio
- ADME/Tox
Mike Biros, Richard Eglen
- Vitra Bioscience
- Innovadyne Technologies
- QTL Biosystems
- Cambrex Corporation
| Program* | ||
|
||
| Thursday, April 21, 2005 | Drugs from the Genome | Chairs: Richard Eglen, John Wang |
| 9:00am | Welcoming Remarks | |
| 9:10am | The Future of Genomic Medicine | Dr. Robert Booth, Celera |
| 9:40am | Optimizing Drug Discovery Efficiency by Target and Therapeutic Area Focus | Dr. Alex Harris, Chiron |
| 10:10am | Discovery of Novel Small Molecule Blockers of T-type Calcium Channels | Dr. Joe McGivern, Amgen |
| 10:40am | Break in Exhibit Hall | |
| 11:00am | Functional Biology for Preclinical Profiling and Biomarker Identification | Dr. Magda Morton, Johnson & Johnson |
| 11:30am | Engineering Therapeutic Antibodies | Dr. Henry Lowman, Genentech |
| 12:00am | Lunch in Exhibit Hall | |
| Thursday, April 21, 2005 | Exploiting Cell Pathways | Chairs: Mike Biros, Heidi Bullock |
| 1:40pm | Cytoskeletal Drug Discovery Technologies: Multi-Protein BiochemicalScreens and Image-Based Cell Assays | Dr. Jeffrey Finer, Cytokinetics |
| 2:20pm | Evolution of GPCR Screening at Roche | Dr. Bruce Koch, Roche Palo Alto |
| 2:50pm | Screening Assays for Scaffold-Based Drug Discovery: The Development of B-RafV599E Inhibitors | Dr. James Tsai, Plexxikon |
| 3:20pm | Break | |
| 3:40pm | Vendor Tutorials | - Aurora Discovery - Cell Signaling Technology - DiscoveRx - MDS Sciex - CyBio |
| 4:30pm | Networking Reception in Exhibit Hall | |
| 5:30-6:30pm | Special Interest Group Meetings | - Academic Outreach Committee - ADME/Tox |
| Friday, April 22, 2005 | Improving Preclinical Validation | Chairs: Mike Biros, Richard Eglen |
| 9:00am | Welcoming Remarks | |
| 9:10am | Keynote: The NIH Chemical Genomics Center: Opening a New Path to Discovery | Dr. Jim Inglese, NIH |
| 9:40am | High-Throughput and High-Content Screening in Academia | Dr. David Solow-Cordero, Stanford University |
| 10:10am | Break in Exhibit Hall | |
| 10:30am | Protein Biomarker Discovery and Assays for Drug Development | Dr. William Rich, Ciphergen |
| 11:00am | Comprehensive Phenotyping and Biomarker Discovery | Dr. Aaron Kantor, Surromed |
| 11:30am | Strategies for Rapid Target Validation in Malaria | Dr. R. Kip Guy, QB3, University of California, San Francisco |
| 12:30pm | Vendor Tutorials | - Genetix - Vitra Bioscience - Innovadyne Technologies - QTL Biosystems - Cambrex Corporation |
| * Times and speakers are subject to change. | ||